BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24907641)

  • 1. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
    Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
    Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
    Eide PW; Cekaite L; Danielsen SA; Eilertsen IA; Kjenseth A; Fykerud TA; Ågesen TH; Bruun J; Rivedal E; Lothe RA; Leithe E
    Cell Signal; 2013 Jan; 25(1):12-8. PubMed ID: 22974840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN.
    Hang X; Zhu S; Di H; Wu Z; Chu K; Wang J; Xin H; Yu G; Peng H; Miao X; Xu W
    Cell Physiol Biochem; 2016; 39(2):768-79. PubMed ID: 27467187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
    Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
    Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.
    Perfetti A; Greco S; Fasanaro P; Bugiardini E; Cardani R; Garcia-Manteiga JM; Riba M; Cittaro D; Stupka E; Meola G; Martelli F
    PLoS One; 2014; 9(4):e93983. PubMed ID: 24722564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN and NEDD4 in Human Breast Carcinoma.
    Chen Y; van de Vijver MJ; Hibshoosh H; Parsons R; Saal LH
    Pathol Oncol Res; 2016 Jan; 22(1):41-7. PubMed ID: 26276352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.
    Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
    Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW
    Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth.
    Hsia HE; Kumar R; Luca R; Takeda M; Courchet J; Nakashima J; Wu S; Goebbels S; An W; Eickholt BJ; Polleux F; Rotin D; Wu H; Rossner MJ; Bagni C; Rhee JS; Brose N; Kawabe H
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13205-10. PubMed ID: 25157163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes.
    Leonard MK; Hill NT; Grant ED; Kadakia MP
    Arch Dermatol Res; 2013 Oct; 305(8):733-9. PubMed ID: 23589096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension.
    Koncarevic A; Jackman RW; Kandarian SC
    FASEB J; 2007 Feb; 21(2):427-37. PubMed ID: 17172638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.
    Li H; Mohamed AA; Sharad S; Umeda E; Song Y; Young D; Petrovics G; McLeod DG; Sesterhenn IA; Sreenath T; Dobi A; Srivastava S
    Oncotarget; 2015 Jun; 6(17):15137-49. PubMed ID: 25883222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDLIM7 is a novel target of the ubiquitin ligase Nedd4-1 in skeletal muscle.
    D'Cruz R; Plant PJ; Pablo LA; Lin S; Chackowicz J; Correa J; Bain J; Batt J
    Biochem J; 2016 Feb; 473(3):267-76. PubMed ID: 26556890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
    Weng M; Luo ZL; Wu XL; Zeng WZ
    Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
    Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
    Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.